Loss-of-function mutations in FancJ genes are found in FA patients as well as in breast cancer patients suggesting that FancJ is a bona fide tumor suppressor (Cantor and Guillemette, 2011; Suhasini and Brosh, 2013). The gene discussed is BRIP1; the disease is breast cancer.